Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03666273
Title A First-in-human Study of ILDR2 (Immunoglobulin-like Domain Containing Receptor 2) Function-blocking Antibody BAY1905254
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bayer
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Arizona Cancer Center Tucson Arizona 85724 United States Details
Yale University School of Medicine New Haven Connecticut 06510 United States Details
University of Chicago Hospitals Chicago Illinois 60637 United States Details
Henry Ford Health System Detroit Michigan 48202 United States Details
University Hospitals Cleveland Medical Center Cleveland Ohio 44106 United States Details
Ohio State University Columbus Ohio 43210 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
South Texas Accelerated Research Therapeutics | START San Antonio San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field